belzutifan
merck
['litespark-004', 'belzutifan']
litespark-004 (mk-6482-004) phase 2 study of belzutifan, an oral hif-2 inhibitor, for von hippel-lindau disease: update with more than two years of follow-up data. presentation by . #asco22 coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology